History
# Registration date Revision Id
2 2019-12-14, 1398/09/23 114790
1 2019-01-14, 1397/10/24 75224
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • Protocol summary

    the Long Term Therapeutic Effect of Short Term Oral Corticosteroid Treatment in Patients with Acquired Lumbar Canal Stenosis.
    The Therapeutic Effect of Short Term Oral Corticosteroid Treatment in Patients with Acquired Lumbar Canal Stenosis.
    تعیین تاثیر دوره کوتاه مدت درمان با کورتیکواستیروئید خوراکی(برای یک هفته) در برطرف کردن علایم به شکل طولانی مدت(برای 2 ماه) در افراد با تنگی کانال نخاعی اکتسابی کمری.
    تعیین تاثیر دوره کوتاه مدت درمان با کورتیکواستیروئید خوراکی(برای یک هفته) در برطرف کردن علایم برای 2 ماه در افراد با تنگی کانال نخاعی اکتسابی کمری.
    A Clinical Trial Study with Control Group with Parallel, One blind and Randomized Groups with 100 Patients.
    Double-blinded Randomized Placebo-Controlled Clinical Trial
    مطالعه کارآزمایی بالینی دارای گروه کنترل،با گروه های موازی،یک سویه کور و تصادفی با 100 بیمار
    کارآزمایی بالینی تصادفی شده دوسوکور و کنترل شده با پلاسبو
    Patients with clinical sign and symptoms of lumbar spinal stenosis Referred to the Orthopedic Clinic of Isfahan University of Medical Sciences are Divided into Two Groups. Group 1 Received Prednisolone Tablets (70 mg) for One Week and treated with Pills of Meloxicam and Pantoprazole and Vitamin E for 20 Days. The Group 2 was Treated with Meloxicam Tablets and Pantoprazole and Vitamin E for 20 days, and the Clinical Symptoms of the Patient were Compared Before intervention and 2 Months Later.
    Patients with clinical sign and symptoms of acquired lumbar spinal stenosis referred to the Orthopedic Clinic of Isfahan University of Medical Sciences are divided into two Groups. Group 1 received prednisolone tablets (10 mg per day) for one week and treated with Meloxicam, Pantoprazole, Vitamin E for 20 Days. The Group 2 was treated with Placebo, Meloxicam, Pantoprazole, Vitamin E for 20 days, and the clinical symptoms of the patient were compared before intervention and 2 months later.
    بیماران با علایم تنگی کانال نخاعی مراجعه کننده به کلینیک ویژه ارتوپدی دانشگاه علوم پزشکی اصفهان به دو گروه تقسیم میشوند.یک گروه به مدت یک هفته تحت درمان با قرص پردنیزولون(70 میلی گرم ) و به مدت 20 روز تحت درمان با قرص ملوکسیکام و پنتوپرازول و ویتامین ای قرار می گیرند و گروه دیگر به مدت 20 روز تحت درمان با قرص ملوکسیکام و پنتوپرازول و ویتامین ای قرار می گیرند و علایم بالینی بیمار قبل از مداخله و 2 ماه بعد مقایسه میشود.
    بیماران با علایم تنگی کانال نخاعی اکتسابی مراجعه کننده به کلینیک ویژه ارتوپدی دانشگاه علوم پزشکی اصفهان به دو گروه تقسیم میشوند. یک گروه به مدت یک هفته تحت درمان با قرص پردنیزولون (10 میلی گرم در روز برای 7 روز ) و به مدت 20 روز تحت درمان با قرص ملوکسیکام و پنتوپرازول و ویتامین ای قرار می گیرند و گروه دیگر به مدت 20 روز تحت درمان با قرص ملوکسیکام، پنتوپرازول، ویتامین ای و پلاسبو قرار می گیرند و علایم بالینی بیمار قبل از مداخله و 2 ماه بعد مقایسه میشود.
    Inclusion Criteria: Acquired Lumbar Spinal Canal Stenosis, Age Over 18 Years Exclusion Criteria:History of Corticosteroid Use in The Last Three Months, Concomitant with Other Systemic Diseases, Such as high Blood Pressure, Diabetes , history of previous surgery on the spine
    Inclusion criteria: written informed consent forms, age>18 years, ALSS, and no history of corticosteroid susceptibility. Exclusion criteria: dissatisfaction of the patients to continue the project, severe allergic reaction to oral corticosteroid, have comorbidities (e.g. gastroesophageal reflux disease, dyspepsia, hypertension, renal failure, diabetes mellitus, BMI>30 kilograms per square meter), recent infection within 3 months ago or hospital admission for the same reasons, neuromuscular disease, history of consuming any corticosteroid in the last three months for any kind of disease, history of any surgery on the spine, history of gastrointestinal bleeding, and the need for spinal surgery or additional medications during the study.
    A Total of 100 Patients with Spinal Stenosis Were Selected Randomly According to Clinical Manifestations and MRI Findings. Group 1 was Treated With Prednisolone Tablets, Meloxicam and Pantoprazole and Vitamin E, While Group 2 was Treated with Meloxicam and Pantoprazole and vitamin E.
    The intervention group received an additional oral prednisolone 10 mg each day for one week.The control group received a placebo just like the real prednisolone.
    تعداد 100 بیمار مبتلا به تنگی کانال نخاعی بر اساس علایم بالینی و یافته های ام آر آی به روش تصادفی انتخاب میشوند و یک گروه تحت درمان با قرص پردنیزولون و ملوکسیکام و پنتوپرازول و ویتامین ای قرار می گیرد و گروه دیگر تحت درمان ملوکسیکلم و پنتوپرازول و ویتامین ای قرار میگیرد.
    گروه مداخله 10 میلی گرم پردنیزولون روزی 1 بار برای 1 هفته دریافت می کند و گروه کنترل پلاسبوی مشابه با همین مدت زمانی مصرف می کند.
    Patient Distance Quality of Life pain
    Ability to Walk painlessly Oswestry Disability Index Severity of pain
    مسافت بیمار کیفیت زندگی درد
    مسافت راه رفتن بدون درد کیفیت زندگی بر اساس اندکس ناتوانی اوسوستری شدت درد
  • General information

    Not randomized
    Randomized
    Single blinded
    Double blinded
    1
    1
    1
    1
    1
    Not used
    Used
    empty
    93
    empty
    2019-01-21, 1397/11/01
    empty
    2019-04-09, 1398/01/20
    empty
    2019-06-20, 1398/03/30
    empty
    Revising the RCT protocol for elucidating the process of the study and adding important information and declaring the end of the study
    empty
    اصلاح کردن پروتوکل کارآزمایی بالینی و اضافه کردن نکات ضروری و مهم جهت شفاف سازی از روند انجان مطالعه و اطلاع دهی از خاتمه مطالعه
    Investigation of Long Term Therapeutic Effect of Short Term Oral Corticosteroid Treatment in Patients with Acquired Lumbar Canal Stenosis.
    Investigating The Effects of Short Term Oral Corticosteroid Treatment in Patients with Acquired Lumbar Canal Stenosis.
    بررسی تاثیر دوره کوتاه مدت درمان با کورتیکواستروئید خوراکی در برطرف کردن علایم به شکل طولانی مدت در افراد با تنگی کانال نخاعی اکتسابی
    بررسی تاثیر دوره کوتاه مدت درمان با کورتیکواستروئید خوراکی در برطرف کردن علایم در افراد با تنگی کانال نخاعی اکتسابی
    Written Consent to Enter Study
    Age Over 18 Years
    Acquired Spinal Canal Stenosis
    No History of Corticosteroid Susceptibility
    Written Consent to Enter Study
    Age Over 18 Years
    Acquired Lumbar Spinal Canal Stenosis
    No History of Corticosteroid Susceptibility
    رضایت کتبی آگاهانه جهت ورود به مطالعه
    سن بالای 18 سال
    ابتلا به تنگی کانال نخاعی اکتسابی
    عدم وجود سابقه حساسیت به کورتیکواستروئید
    رضایت کتبی آگاهانه جهت ورود به مطالعه
    سن بالای 18 سال
    ابتلا به تنگی کانال نخاعی اکتسابی در ناحیه کمر
    عدم وجود سابقه حساسیت به کورتیکواستروئید
    Concomitant With Other Systemic Diseases, Such as Blood pressure, Diabetes.
    History of Corticosteroid Use in The Last Three Months.
    Concomitant With Other Systemic Diseases, Such as Blood pressure, Diabetes, BMI>30 kg/m2, Gastroesophageal reflux disease, dyspepsia, renal failure, neuromuscular disorders
    History of Corticosteroid Use in The Last Three Months.
    Needing spinal surgery for Acquired Spinal Canal Stenosis
    Recent infection within 3 months ago or hospital admission for the same reasons
    Incidence of drug complications/severe allergic reaction to oral corticosteroid
    history of any surgery on the spine
    history of gastrointestinal bleeding
    ابتلا همزمان به بیماری های سیستمیک دیگر مانند فشارخون ، دیابت
    سابقه مصرف کورتیکواستروئید در سه ماه گذشته
    ابتلا همزمان به بیماری های سیستمیک دیگر مانند فشارخون ، دیابت، شاخص توده بدنی بالای 30، ریفلاکس معده ای-مروی، دیس پپسی، نارسایی کلیه، بیماری های نوروماسکولار،
    سابقه مصرف کورتیکواستروئید در سه ماه گذشته
    نیازمند عمل جراحی بر روی کمر به علت تنگی کانال نخاعی اکتسابی
    سابقه عفونت یا بستری به این علت در بیمارستان در 3 ماه گذشته
    سابقه آلرژی به داروهای کورتونی
    سابقه هرگونه عمل جراحی بر روی ستون فقرات
    سابقه خونریزی گوارشی
    The patients were allocated into intervention or control group using block randomization method to keep an even randomization ratio of (1:1). If the patient had inclusion criteria and did not excluded from the study according to above mentioned protocol, the random number generating software was used to determine their designated group. Numbers were between 0-9. If the number was even, the letter "A" was wrote at the top of their checklist by the examining physician, and if the number was odd, the letter "B" was used. Then, the next patient had to be assigned to the opposite group. This process repeated for the upcoming patients and continued until we reached our estimated sample size. After completing the study and before starting the data analysis process, the encrypted letters were revealed by the pharmaceutical company. The letter "A" was assigned to the intervention group and the letter "B" was assigned to the control group.
    پس از بررسی معیارهای ورود و خروج نمونه ها، بیماران به صورت بلوک بندی شده و به صورت نسبت 1 به 1 با نرم افزار تولید کننده اعداد تصادفی که اعدادی بین 0 تا 9 تولید می کند به 2 گروه مداخله و کنترل تقسیم می شوند. در صورت رونمایی از یک عدد زوج، حرف آ در بالای پرونده بیمار نوشته می شود و در صورت رونمایی از یک عدد فرد، حرف ب در بالای پرونده نوشته خواهد شد. سپس بیمار به اتاق بعدی فرستاده می شود. برای حفظ نسبت 1 به 1 بیمار بعدی در گروه مقابل قرار می گیرد و این روند برای بیماران بعدی تکرار می شود تا حجم نمونه به حد نصاب برسد.
    The Data Analyzer Has been Blinded to Control and Intervention Groups.
    This study was conducted with double-blinded method. Neither the patients who were included in this study nor the researchers knew about the assignments of groups to either intervention or control. After determining the designated letter, the patients were visited by another researcher who gave the drugs to the patients. A blinded pharmacist who worked in our university hospital pharmacy bought the drugs from the pharmaceutical companies, put them in the designated group ("A" (intervention) or "B" (control) according to the pharmaceutical company policies), and gave the specific package of drugs to the patients (both of them had three active drugs, prednisolone or placebo were different between those bags) with full information of how to use them.
    آنالیز کننده داده نسبت به گروه های کنترل و مداخله کور شده است.
    دوسوکور در این مطالعه به نحوی انجام می شود که پزشکی که بیماران را مورد ارزیابی قرار می دهد و معیارهای ورود و خروج را بررسی می کند و در آینده پیامدهای مطالعه را مورد ارزیابی قرار می دهد، خود بیماران دخیل در مطالعه و همچنین فردی که کیسه دارویی بیمار که توسط دکتر داروساز تهیه شده است را به بیماران می دهد از نحوه ی تقسیم بیماران به گروه مداخله یا کنترل که یکی آ می باشد و دیگری ب خبر نخواهد داشت. بیماران پس از ویزیت توسط پزشک مسول طرح، و مشخص کردن تقسیم شدنشان به گروه آ یا ب توسط نرم افزار تولید کننده اعداد تصادفی، به اتاق دیگر راهنمایی می شوند که در آن یک محقق دیگر با استفاده از حرفی که بر روی پرونده بیماران نوشته شده کیسه دارویی تهیه شده از قبل که بر روی یکی حرف آ نوشته شده است و بر روی دیگری ب را به بیماران تحویل می دهد. در هر کیسه 4 مدل دارو می باشد که 3 تای آن داروی فعال می باشد و یکی از آن بین دوگروه متفاوت است. از داروهای مشابه در هر دوکیسه پنتوپرازول 20 میلی گرم، ملوکسی کام 7.5 میلی گرم و ویتامین ای 400 واحد می باشد. داروی متفاوت در یکی از گروهها پردنیزولون 10 میلی گرم است و در کیسه دیگر پلاسبوی کاملا مشابه قرار دارد. دستور مصرف هر 4 دارو مشابه هم به بیمار توضیح داده می شود. پس از پایان مطالعه و بررسی نتایج درمان پس از 2 ماه، اطلاعات رمزگذاری شده در مورد گروه ها آشکار شده و داده ها جهت آنالیز به آنالیزور داده می شود.
  • Primary outcomes

    #1
    Distance
    Walking Distance
    میزان مسافت
    مسافت راه رفتن
    #2
    Quality of Life
    Oswestry Disability Index from Oswestry Low Back Pain questionnaire
    کیفیت زندگی
    شاخص ناتوانی اوسوستری
  • Secondary outcomes

    #1
    The Amount of Pain
    Severity of pain
    میزان درد
    شدت درد
  • Intervention groups

    #1
    Intervention Group: Taking 10 mg of Prednisolone Daily for One Week, Meloxicam tablets 7.5 Mg and Vitamin E and Pantoprazole 20 Mg for 20 days and Recording the Clinical Symptoms and Quality of Life Before the Intervention and 2 Months Later.
    Intervention Group: Prednisolone 10 mg per day for one week, Meloxicam 7.5 mg per day, Vitamin E 400 IU and Pantoprazole 20 mg for 20 days
    گروه مداخله:مصرف ده میلی گرم قرص پردنیزولون روزانه به مدت یک هفته،قرص ملوکسیکام هفت و نیم میلی گرم و ویتامین ای و پنتوپرازول بیست میلی گرم به مدت ۲۰ روز و ثبت علایم بالینی و کیفیت زندگی قبل از شروع مداخله و 2 ماه بعد.
    گروه مداخله: مصرف ده میلی گرم قرص پردنیزولون روزانه به مدت یک هفته، قرص ملوکسیکام هفت و نیم میلی گرم و ویتامین ای 400 واحد و پنتوپرازول بیست میلی گرم به مدت ۲۰ روز
    #2
    Control Group:Taking Meloxicam 7.5 Mg and vitamin E and Pantoprazole 20 Mg for 20 days and Recording Clinical Symptoms and Quality of Life Before the Intervention and 2 Months Later.
    Control Group: Meloxicam 7.5 mg per day, Vitamin E 400 IU and Pantoprazole 20 mg for 20 days, and placebo for 10 days
    گروه کنترل: مصرف قرص ملوکسیکام هفت و نیم میلی گرم و ویتامین ای و پنتوپرازول بیست میلی گرم به مدت ۲۰ روز و ثبت علایم بالینی و کیفیت زندگی قبل از شروع مداخله و 2 ماه بعد.
    گروه کنترل: مصرف قرص ملوکسیکام هفت و نیم میلی گرم و ویتامین ای 400 واحد و پنتوپرازول 20 میلی گرم به مدت ۲۰ روز و پلاسبو مشابه داروی اصلی به مدت 10 روز
  • Recruitment centers

    #1
    Name of recruitment center - English: Orthopedic Clinic of Alzahra Hospital
    Name of recruitment center - Persian: درمانگاه ارتوپدی بیمارستان الزهرا
    Full name of responsible person - English: Hossein Akbariaghdam
    Full name of responsible person - Persian: حسین اکبری اقدم
    Street address - English: Sofah Boulevard., Alzahra Hospital
    Street address - Persian: بلوار صفه، بیمارستان الزهرا
    City - English: Esfahan
    City - Persian: اصفهان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8174675731
    Phone: +98 31 3668 5149
    Fax:
    Email: Akbariaghdam@med.mui.ac.ir
    Web page address:
    Name of recruitment center - English: Orthopedic Clinic of Alzahra Hospital
    Name of recruitment center - Persian: درمانگاه ارتوپدی بیمارستان الزهرا
    Full name of responsible person - English: Hossein Akbariaghdam
    Full name of responsible person - Persian: حسین اکبری اقدم
    Street address - English: Alzahra Hospital, Soffeh Street, Isfahan
    Street address - Persian: اصفهان، خیابان شهدای صفه، بیمارستان الزهرا
    City - English: Esfahan
    City - Persian: اصفهان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8174675731
    Phone: +98 31 3668 5149
    Fax:
    Email: Akbariaghdam@med.mui.ac.ir
    Web page address:
    #2
    Name of recruitment center - English: Orthopedic Clinic of Kashani Hospital
    Name of recruitment center - Persian: درمانگاه ارتوپدی بیمارستان کاشانی
    Full name of responsible person - English: Hossein Akbariaghdam
    Full name of responsible person - Persian: حسین اکبری اقدم
    Street address - English: Kashani Street., Kashani Hospital
    Street address - Persian: خیابان کاشانی، بیمارستان کاشانی
    City - English: Esfahan
    City - Persian: اصفهان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8183983434
    Phone: +98 31 3233 0091
    Fax:
    Email: Akbariaghdam@med.mui.ac.ir
    Web page address:
    Name of recruitment center - English: Orthopedic Clinic of Kashani Hospital
    Name of recruitment center - Persian: درمانگاه ارتوپدی بیمارستان کاشانی
    Full name of responsible person - English: Hossein Akbariaghdam
    Full name of responsible person - Persian: حسین اکبری اقدم
    Street address - English: Kashani Hospital., kashani Street,Isfahan
    Street address - Persian: اصفهان ،خیابان کاشانی، بیمارستان کاشانی
    City - English: Esfahan
    City - Persian: اصفهان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8183983434
    Phone: +98 31 3233 0091
    Fax:
    Email: Akbariaghdam@med.mui.ac.ir
    Web page address:
  • Sponsors / Funding sources

    #1

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Hossein Akbariaghdam
    Full name of responsible person - Persian: حسین اکبری اقدم
    Street address - English: Hezar Jereb Street, Isfahan University of Medical Sciences
    Street address - Persian: خیابان هزار جریب ،دانشگاه علوم پزشکی اصفهان
    City - English: Esfahan
    City - Persian: اصفهان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8174673461
    Phone: +98 31 3668 0048
    Fax:
    Email: Akbariaghdam@med.mui.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Hossein Akbariaghdam
    Full name of responsible person - Persian: حسین اکبری اقدم
    Street address - English: Isfahan University of Medical Science, Hezar Jereb Street, Isfahan
    Street address - Persian: اصفهان،خیابان هزار جریب ،دانشگاه علوم پزشکی اصفهان
    City - English: Esfahan
    City - Persian: اصفهان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8174673461
    Phone: +98 31 3668 0048
    Fax:
    Email: Akbariaghdam@med.mui.ac.ir
    Web page address:

Protocol summary

Study aim
The Therapeutic Effect of Short Term Oral Corticosteroid Treatment in Patients with Acquired Lumbar Canal Stenosis.
Design
Double-blinded Randomized Placebo-Controlled Clinical Trial
Settings and conduct
Patients with clinical sign and symptoms of acquired lumbar spinal stenosis referred to the Orthopedic Clinic of Isfahan University of Medical Sciences are divided into two Groups. Group 1 received prednisolone tablets (10 mg per day) for one week and treated with Meloxicam, Pantoprazole, Vitamin E for 20 Days. The Group 2 was treated with Placebo, Meloxicam, Pantoprazole, Vitamin E for 20 days, and the clinical symptoms of the patient were compared before intervention and 2 months later.
Participants/Inclusion and exclusion criteria
Inclusion criteria: written informed consent forms, age>18 years, ALSS, and no history of corticosteroid susceptibility. Exclusion criteria: dissatisfaction of the patients to continue the project, severe allergic reaction to oral corticosteroid, have comorbidities (e.g. gastroesophageal reflux disease, dyspepsia, hypertension, renal failure, diabetes mellitus, BMI>30 kilograms per square meter), recent infection within 3 months ago or hospital admission for the same reasons, neuromuscular disease, history of consuming any corticosteroid in the last three months for any kind of disease, history of any surgery on the spine, history of gastrointestinal bleeding, and the need for spinal surgery or additional medications during the study.
Intervention groups
The intervention group received an additional oral prednisolone 10 mg each day for one week.The control group received a placebo just like the real prednisolone.
Main outcome variables
Ability to Walk painlessly Oswestry Disability Index Severity of pain

General information

Reason for update
Revising the RCT protocol for elucidating the process of the study and adding important information and declaring the end of the study
Acronym
IRCT registration information
IRCT registration number: IRCT20180729040636N1
Registration date: 2019-01-14, 1397/10/24
Registration timing: prospective

Last update: 2019-12-22, 1398/10/01
Update count: 1
Registration date
2019-01-14, 1397/10/24
Registrant information
Name
Hossein Akbari aghdam
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 3620 2085
Email address
akbariaghdam@med.mui.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2019-01-18, 1397/10/28
Expected recruitment end date
2019-03-19, 1397/12/28
Actual recruitment start date
2019-01-21, 1397/11/01
Actual recruitment end date
2019-04-09, 1398/01/20
Trial completion date
2019-06-20, 1398/03/30
Scientific title
Investigating The Effects of Short Term Oral Corticosteroid Treatment in Patients with Acquired Lumbar Canal Stenosis.
Public title
Effect of Corticosteroid in Lumbar Spinal Canal Stenosis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Written Consent to Enter Study Age Over 18 Years Acquired Lumbar Spinal Canal Stenosis No History of Corticosteroid Susceptibility
Exclusion criteria:
Concomitant With Other Systemic Diseases, Such as Blood pressure, Diabetes, BMI>30 kg/m2, Gastroesophageal reflux disease, dyspepsia, renal failure, neuromuscular disorders History of Corticosteroid Use in The Last Three Months. Needing spinal surgery for Acquired Spinal Canal Stenosis Recent infection within 3 months ago or hospital admission for the same reasons Incidence of drug complications/severe allergic reaction to oral corticosteroid history of any surgery on the spine history of gastrointestinal bleeding
Age
From 18 years old
Gender
Both
Phase
2
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 100
Actual sample size reached: 93
Randomization (investigator's opinion)
Randomized
Randomization description
The patients were allocated into intervention or control group using block randomization method to keep an even randomization ratio of (1:1). If the patient had inclusion criteria and did not excluded from the study according to above mentioned protocol, the random number generating software was used to determine their designated group. Numbers were between 0-9. If the number was even, the letter "A" was wrote at the top of their checklist by the examining physician, and if the number was odd, the letter "B" was used. Then, the next patient had to be assigned to the opposite group. This process repeated for the upcoming patients and continued until we reached our estimated sample size. After completing the study and before starting the data analysis process, the encrypted letters were revealed by the pharmaceutical company. The letter "A" was assigned to the intervention group and the letter "B" was assigned to the control group.
Blinding (investigator's opinion)
Double blinded
Blinding description
This study was conducted with double-blinded method. Neither the patients who were included in this study nor the researchers knew about the assignments of groups to either intervention or control. After determining the designated letter, the patients were visited by another researcher who gave the drugs to the patients. A blinded pharmacist who worked in our university hospital pharmacy bought the drugs from the pharmaceutical companies, put them in the designated group ("A" (intervention) or "B" (control) according to the pharmaceutical company policies), and gave the specific package of drugs to the patients (both of them had three active drugs, prednisolone or placebo were different between those bags) with full information of how to use them.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Isfahan University of Medical Sciences
Street address
Isfahan University of Medical Sciences & Health Services, Building No. 4, Hazar Jarib Street
City
Esfahan
Province
Isfehan
Postal code
۸۱۷۴۶-۷۳۴۶۱
Approval date
2018-09-01, 1397/06/10
Ethics committee reference number
IR.MUI.RESEARCH.REC.1397.149

Health conditions studied

1

Description of health condition studied
Acquired Lumbar Spinal Canal stenosis
ICD-10 code
M48.06
ICD-10 code description
Spinal stenosis, lumbar region

Primary outcomes

1

Description
Walking Distance
Timepoint
Before the Intervention and 2 Months Later.
Method of measurement
Metre

2

Description
Oswestry Disability Index from Oswestry Low Back Pain questionnaire
Timepoint
Before the Intervention and 2 Months Later.
Method of measurement
OSWESTRY LOW BACK PAIN SCORE QUESTIONNAIRE

Secondary outcomes

1

Description
Severity of pain
Timepoint
Before the Intervention and 2 Months Later
Method of measurement
PAIN Numerical Rating Scale

2

Description
Low Back Pain
Timepoint
Before the Intervention and 2 Months Later
Method of measurement
Check List

Intervention groups

1

Description
Intervention Group: Prednisolone 10 mg per day for one week, Meloxicam 7.5 mg per day, Vitamin E 400 IU and Pantoprazole 20 mg for 20 days
Category
Treatment - Drugs

2

Description
Control Group: Meloxicam 7.5 mg per day, Vitamin E 400 IU and Pantoprazole 20 mg for 20 days, and placebo for 10 days
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Orthopedic Clinic of Alzahra Hospital
Full name of responsible person
Hossein Akbariaghdam
Street address
Alzahra Hospital, Soffeh Street, Isfahan
City
Esfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3668 5149
Email
Akbariaghdam@med.mui.ac.ir

2

Recruitment center
Name of recruitment center
Orthopedic Clinic of Kashani Hospital
Full name of responsible person
Hossein Akbariaghdam
Street address
Kashani Hospital., kashani Street,Isfahan
City
Esfahan
Province
Isfehan
Postal code
8183983434
Phone
+98 31 3233 0091
Email
Akbariaghdam@med.mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Hossein Akbariaghdam
Street address
Isfahan University of Medical Science, Hezar Jereb Street, Isfahan
City
Esfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0048
Email
Akbariaghdam@med.mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Hossein Akbariaghdam
Position
Assistant Professor of Orthopedics
Latest degree
Specialist
Other areas of specialty/work
Orthopedics
Street address
Kashani Hospital
City
Esfahan
Province
Isfehan
Postal code
8183983434
Phone
+98 31 3620 2085
Email
Akbariaghdam@med.mui.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Hossein Akbariaghdam
Position
Assistant Professor of Orthopedics
Latest degree
Specialist
Other areas of specialty/work
Orthopedics
Street address
Kashani Hospital, Kashani Street, Isfahan
City
Esfahan
Province
Isfehan
Postal code
8183983434
Phone
+98 31 3620 2085
Email
Akbariaghdam@med.mui.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Hossein Akbariaghdam
Position
Assistant Professor of Orthopedics
Latest degree
Specialist
Other areas of specialty/work
Orthopedics
Street address
Kashani Hospital, Kashani Street
City
Esfahan
Province
Isfehan
Postal code
8183983434
Phone
+98 31 3620 2085
Email
Akbariaghdam@med.mui.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...